Nine in 10 providers encountered prescription drug shortages in the second half of 2010, according to a survey by Premier Healthcare Alliance. Fully 80% of respondents indicated that the shortages caused...
Book offers nurses advice on genetic challenges
Feb 07, 2018
A new book focuses on genetics and genomic essentials for graduate-level nurses.
Drug sales flat in the U.S. last year, according to IMS
Mar 24, 2009
Domestic prescription drug sales grew 1.3% in 2008 to $291 billion amid increased use of generics, lower sales of new products and slackening consumer demand resulting from the economic downturn, according...
Omnicare shows second quarter profit
By
McKnight's Staff
Aug 01, 2012
Omnicare Inc. turned a profit in the second quarter, according to a statement from the nursing home pharmacy giant. Omnicare earned $18.7 million, or 17 cents per share, for the three months ended June...
Drug shortage may last for a while
Nov 27, 2012
More than 100 medicines now appear on the government’s drug shortage list. Those most often in short supply include anesthetics and oncological drugs, according to the Food & Drug Administration....
Pharma company expands in Tennessee
May 03, 2017
Aphena Pharma Solutions announced it has expanded its solid-dose packaging operations in Cookeville, TN. The expansion doubled the size of the facility, increasing manufacturing and warehouse space, and...
Mayo Clinic receives patent for GeneSight
May 22, 2013
The Mayo Clinic has received a patent for a new medication selection procedure. GeneSight uses a test to prioritize the selection of medications for patients with depression, chronic pain and other psychiatric...
Seroquel generics okay, appeals court says
May 01, 2013
AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension...
Winners announced for Scheduler of the Year
Apr 11, 2017
OnShift has announced the winners of its annual Scheduler of the Year Awards last week.
Lung cancer mutation test approved
May 29, 2013
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.